CENCORA, INC. Repayments of Lines of Credit
CENCORA, INC. (COR) reported Repayments of Lines of Credit of $83.78 billion for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLinesOfCredit · last filed 2026-08-05
- CENCORA, INC. repayments of lines of credit for the quarter ending 2026-06-30 was $12.85B, a 70.23% decline year-over-year.
- CENCORA, INC. repayments of lines of credit for the quarter ending 2026-03-31 was $47.42B, a 60.64% increase year-over-year.
- CENCORA, INC. repayments of lines of credit for the quarter ending 2025-12-31 was $23.50B, a 75.03% increase year-over-year.
- CENCORA, INC. repayments of lines of credit for the quarter ending 2025-09-30 was $46.05B, a 244.40% increase year-over-year.
- CENCORA, INC. repayments of lines of credit for fiscal 2022 was $4.67B, a 8.10% decline from fiscal 2021.
- CENCORA, INC. repayments of lines of credit for fiscal 2021 was $5.08B, a 3289.74% increase from fiscal 2020.
- CENCORA, INC. repayments of lines of credit for fiscal 2020 was $149.98M, a 80.50% decline from fiscal 2019.
- CENCORA, INC. repayments of lines of credit for fiscal 2019 was $769.28M, a 96.94% decline from fiscal 2018.
| Period end | Repayments of Lines of Credit 3 month | Repayments of Lines of Credit 6 month | Repayments of Lines of Credit 9 month | Repayments of Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $12.85B derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-05 | $60.28B derived: sum of 2 quarters · filed 2026-08-05 | $83.78B 10-Q · filed 2026-08-05 | $129.82B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $47.42B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-06 | $70.93B 10-Q · filed 2026-05-06 | $116.97B derived: sum of 3 quarters · filed 2026-05-06 | $160.14B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $23.50B 10-Q · filed 2026-02-04 | $69.55B derived: sum of 2 quarters · filed 2026-02-10 | $112.72B derived: sum of 3 quarters · filed 2026-08-05 | $142.24B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-09-30 | $46.05B derived: 8-K 12 month − 10-Q 9 month · filed 2026-02-10 | $89.22B derived: sum of 2 quarters · filed 2026-08-05 | $118.74B derived: sum of 3 quarters · filed 2026-08-05 | $132.17B 8-K · filed 2026-02-10 |
| 2025-06-30 | $43.17B derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-05 | $72.69B derived: sum of 2 quarters · filed 2026-08-05 | $86.12B 10-Q · filed 2026-08-05 | $99.49B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $29.52B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-06 | $42.95B 10-Q · filed 2026-05-06 | $56.32B derived: sum of 3 quarters · filed 2026-05-06 | $65.08B derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $13.43B 10-Q · filed 2026-02-04 | $26.80B derived: sum of 2 quarters · filed 2026-02-10 | $35.56B derived: sum of 3 quarters · filed 2026-02-10 | $72.35B derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-09-30 | $13.37B derived: 8-K 12 month − 10-Q 9 month · filed 2026-02-10 | $22.14B derived: sum of 2 quarters · filed 2026-02-10 | $58.93B derived: sum of 3 quarters · filed 2026-02-10 | $70.11B 8-K · filed 2026-02-10 |
| 2024-06-30 | $8.77B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-06 | $45.56B derived: sum of 2 quarters · filed 2025-08-06 | $56.74B 10-Q · filed 2025-08-06 | $85.14B derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $36.79B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-07 | $47.98B 10-Q · filed 2025-05-07 | $76.38B derived: sum of 3 quarters · filed 2026-02-10 | $90.39B derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $11.19B 10-Q · filed 2025-02-05 | $39.59B derived: sum of 2 quarters · filed 2026-02-10 | $53.60B derived: sum of 3 quarters · filed 2026-02-10 | $87.48B derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-09-30 | $28.40B derived: 8-K 12 month − 10-Q 9 month · filed 2026-02-10 | $42.41B derived: sum of 2 quarters · filed 2026-02-10 | $76.29B derived: sum of 3 quarters · filed 2026-02-10 | $78.19B 8-K · filed 2026-02-10 |
| 2023-06-30 | $14.01B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-31 | $47.89B derived: sum of 2 quarters · filed 2024-07-31 | $49.79B 10-Q · filed 2024-07-31 | $50.23B derived: sum of 4 quarters · filed 2024-11-26 |
| 2023-03-31 | $33.89B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-01 | $35.78B 10-Q · filed 2024-05-01 | $36.22B derived: sum of 3 quarters · filed 2024-11-26 | $36.64B derived: sum of 4 quarters · filed 2024-11-26 |
| 2022-12-31 | $1.89B 10-Q · filed 2024-01-31 | $2.34B derived: sum of 2 quarters · filed 2024-11-26 | $2.75B derived: sum of 3 quarters · filed 2024-11-26 | $5.62B derived: sum of 4 quarters · filed 2024-11-26 |
| 2022-09-30 | $444.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | $856.45M derived: sum of 2 quarters · filed 2024-11-26 | $3.73B derived: sum of 3 quarters · filed 2024-11-26 | $4.67B 10-K · filed 2024-11-26 |
| 2022-06-30 | $412.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-02 | $3.28B derived: sum of 2 quarters · filed 2023-08-02 | $4.23B 10-Q · filed 2023-08-02 | $4.70B derived: sum of 4 quarters · filed 2023-11-21 |
| 2022-03-31 | $2.87B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-02 | $3.82B 10-Q · filed 2023-05-02 | $4.29B derived: sum of 3 quarters · filed 2023-11-21 | $8.87B derived: sum of 4 quarters · filed 2023-11-21 |
| 2021-12-31 | $946.79M 10-Q · filed 2023-02-01 | $1.42B derived: sum of 2 quarters · filed 2023-11-21 | $6.00B derived: sum of 3 quarters · filed 2023-11-21 | $6.03B derived: sum of 4 quarters · filed 2023-11-21 |
| 2021-09-30 | $471.55M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-21 | $5.05B derived: sum of 2 quarters · filed 2023-11-21 | $5.08B derived: sum of 3 quarters · filed 2023-11-21 | $5.08B 10-K · filed 2023-11-21 |
| 2021-06-30 | $4.58B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-03 | $4.61B derived: sum of 2 quarters · filed 2022-08-03 | $4.61B 10-Q · filed 2022-08-03 | $4.61B derived: sum of 4 quarters · filed 2022-11-22 |
| 2021-03-31 | $31.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-04 | $31.26M 10-Q · filed 2022-05-04 | $31.26M derived: sum of 3 quarters · filed 2022-11-22 | $93.98M derived: sum of 4 quarters · filed 2022-11-22 |
| 2020-12-31 | $0.00 10-Q · filed 2022-02-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-22 | $62.72M derived: sum of 3 quarters · filed 2022-11-22 | $95.90M derived: sum of 4 quarters · filed 2022-11-22 |
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22 | $62.72M derived: sum of 2 quarters · filed 2022-11-22 | $95.90M derived: sum of 3 quarters · filed 2022-11-22 | $149.98M 10-K · filed 2022-11-22 |
| 2020-06-30 | $62.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-04 | $95.90M derived: sum of 2 quarters · filed 2021-08-04 | $149.98M 10-Q · filed 2021-08-04 | $182.31M derived: sum of 4 quarters · filed 2021-11-23 |
| 2020-03-31 | $33.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-05 | $87.26M 10-Q · filed 2021-05-05 | $119.59M derived: sum of 3 quarters · filed 2021-11-23 | $316.87M derived: sum of 4 quarters · filed 2021-11-23 |
| 2019-12-31 | $54.08M 10-Q · filed 2021-02-04 | $86.41M derived: sum of 2 quarters · filed 2021-11-23 | $283.69M derived: sum of 3 quarters · filed 2021-11-23 | $737.75M derived: sum of 4 quarters · filed 2021-11-23 |
| 2019-09-30 | $32.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-23 | $229.61M derived: sum of 2 quarters · filed 2021-11-23 | $683.67M derived: sum of 3 quarters · filed 2021-11-23 | $769.28M 10-K · filed 2021-11-23 |
| 2019-06-30 | $197.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-05 | $651.34M derived: sum of 2 quarters · filed 2020-08-05 | $736.96M 10-Q · filed 2020-08-05 | $1.36B derived: sum of 4 quarters · filed 2020-11-19 |
| 2019-03-31 | $454.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07 | $539.67M 10-Q · filed 2020-05-07 | $1.16B derived: sum of 3 quarters · filed 2020-11-19 | $1.25B derived: sum of 4 quarters · filed 2020-11-19 |
| 2018-12-31 | $85.61M 10-Q · filed 2020-01-30 | $707.01M derived: sum of 2 quarters · filed 2020-11-19 | $800.82M derived: sum of 3 quarters · filed 2020-11-19 | $22.64B derived: sum of 4 quarters · filed 2020-11-19 |
| 2018-09-30 | $621.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-19 | $715.21M derived: sum of 2 quarters · filed 2020-11-19 | $22.56B derived: sum of 3 quarters · filed 2020-11-19 | $25.13B 10-K · filed 2020-11-19 |
| 2018-06-30 | $93.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-01 | $21.94B derived: sum of 2 quarters · filed 2019-08-01 | $24.51B 10-Q · filed 2019-08-01 | |
| 2018-03-31 | $21.84B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-02 | $24.41B 10-Q · filed 2019-05-02 | ||
| 2017-12-31 | $2.57B 10-Q · filed 2019-01-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |